Example：10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Population pharmacokinetics of diethylcarbamazine in patients with lymphatic filariasis and healthy individuals Antimicrobial Agents and Chemotherapy (IF5.191), Pub Date : 2021-07-26, DOI: 10.1128/aac.00317-21 Veenu Bala, Yashpal S Chhonker, Abdullah Alshehri, Constant Edi, Catherine M Bjerum, Benjamin G Koudou, Christopher L King, Daryl J Murry
Diethylcarbamazine (DEC) is a drug of choice to treat lymphatic filariasis (LF) either
used alone or in combination as mass drug administration (MDA) preventive strategies.
The objective of this study was to develop a population pharmacokinetic model for